Trading

Data

Solutions

Insights

GreenLight Biosciences Stock

greenlightbiosciences.comHealthcareFounded: 2008Funding to Date: $141.55MM

GreenLight Biosciences is a biotech company leveraging RNA to tackle some of humanity's greatest challenges, including pandemics, rare diseases, biodiversity and climate change.

Learn more about GreenLight Biosciences IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for GreenLight Biosciences.

Register Today

Team

Management Team

Carole Cobb

Chief Operating Officer

Andrey Zarur Ph.D

Co-Founder, Chief Executive Officer, President & Board Member

Mick Messman

Chief Commercial Officer

Marta Ortega-Valle

Co-Founder & Senior Vice President, Corporate Development

Board Members

Colin Steen

Syngenta Ventures

Eric O'Brien

Fall Line Capital

James Swartz Ph.D

Martha Schlicher

Neil Renninger Ph.D

Khosla Ventures

David Furneaux

Kodiak Venture Partners

David Russell Ph.D

Lewis & Clark Ventures

Gregory Lucier

Jonathan Fleming

Oxford Bioscience Partners

Andrey Zarur Ph.D

Charles Cooney Ph.D

Ganesh Kishore Ph.D

Spruce Capital Partners

Mark Cupta

Prelude Ventures

Matthew Walker

Other companies like GreenLight Biosciences in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Healthcare

News

FinSMEs 01/08/2019

GreenLight Biosciences Raises $50M in Funding | FinSMEs

GreenLight Biosciences, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, raised $50m in funding

Popular Topics

Popular Topics

GreenLight Biosciences Stock

Register for Details